MYO-103

N/A

Report date: 2025/08/07 20:00:08

Base Information

Drug NameMYO-103
Drug Alias NameMYO-103SRP-9005
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAVrh74 vector
Mechanisms of ActionGamma-sarcoglycan gene transference
TargetsGamma-sarcoglycan
Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyonexus Therapeutics IncSarepta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophies, Limb-Girdle

Other Information

ATC CodeN/A
Related LinksN/A